Literature DB >> 16125055

M-CSF stimulated differentiation requires persistent MEK activity and MAPK phosphorylation independent of Grb2-Sos association and phosphatidylinositol 3-kinase activity.

Stéphanie Gobert Gosse1, Caroline Bourgin, Wang Qing Liu, Christiane Garbay, Guy Mouchiroud.   

Abstract

Macrophage colony-stimulating factor (M-CSF) is a physiological regulator of monocyte-macrophage lineage. Ectopic expression of the M-CSF receptor (M-CSFR, or Fms) in murine myeloid cell line FDC-P1 (FD/Fms cells) results in M-CSF-dependent macrophage differentiation. Previously, we observed that M-CSF induces two temporally distinct phases of mitogen-activated protein kinase (MAPK) phosphorylation. Here we show that levels of phosphorylated MAPK kinase MEK1 follow the same kinetics as MAPK phosphorylation, characterized by an early and transient phase (the first 30 min of M-CSF stimulation) and a late and persistent phase from 4 h of stimulation. The MEK inhibitor U0126 strongly inhibited both phases of MAPK phosphorylation as well as FD/Fms cell differentiation, indicating that MAPK may relay M-CSF differentiation signaling downstream of M-CSFR. Treatment of FD/Fms cells with U0126 during the first hour of M-CSF stimulation reversibly blocked the early phase of MAPK phosphorylation but did not affect differentiation. In contrast, U0126 still inhibited FD/Fms cell differentiation when its addition was delayed by 24 h. This demonstrated that late and persistent MEK activity is specifically required for macrophage differentiation to occur. Furthermore, disrupting Grb2-Sos complexes with a specific blocking peptide did not prevent FD/Fms cells differentiation in response to M-CSF, nor did it abolish MAPK phosphorylation. The role of phosphatidylinositol 3-kinase (PI 3-kinase), another potential regulator of the MAPK pathway, was examined using the specific inhibitor LY294002. This compound could not impede FD/Fms cell commitment to macrophage differentiation and did not significantly affect MAPK phosphorylation in response to M-CSF. Therefore, M-CSF differentiation signaling in myeloid progenitor cells is mediated through persistent MEK activity but it is not strictly dependent upon Grb2-Sos interaction or PI 3-kinase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125055     DOI: 10.1016/j.cellsig.2005.02.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  18 in total

Review 1.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

2.  Role of Erk1/2 signaling in the regulation of neutrophil versus monocyte development in response to G-CSF and M-CSF.

Authors:  Nan Hu; Yaling Qiu; Fan Dong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

3.  The transcription factor T-box 3 regulates colony-stimulating factor 1-dependent Jun dimerization protein 2 expression and plays an important role in osteoclastogenesis.

Authors:  Chen Yao; Gang-Qing Yao; Ben-Hua Sun; Changqing Zhang; Steven M Tommasini; Karl Insogna
Journal:  J Biol Chem       Date:  2014-01-06       Impact factor: 5.157

4.  T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.

Authors:  Paul D Simoncic; Annie Bourdeau; Ailsa Lee-Loy; Larry R Rohrschneider; Michel L Tremblay; E Richard Stanley; C Jane McGlade
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  Macrophage colony-stimulating factor improves cardiac function after ischemic injury by inducing vascular endothelial growth factor production and survival of cardiomyocytes.

Authors:  Tatsuma Okazaki; Satoru Ebihara; Masanori Asada; Shinsuke Yamanda; Yoshifumi Saijo; Yasuyuki Shiraishi; Takae Ebihara; Kaijun Niu; He Mei; Hiroyuki Arai; Tomoyuki Yambe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

6.  Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.

Authors:  Fernando C Baltanás; Martín Pérez-Andrés; Alicia Ginel-Picardo; David Diaz; David Jimeno; Pilar Liceras-Boillos; Robert L Kortum; Lawrence E Samelson; Alberto Orfao; Eugenio Santos
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

7.  TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.

Authors:  Yue Wang; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Mariuxi C Manukyan; Jeffrey A Poynter; Daniel R Meldrum
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

8.  Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.

Authors:  Chun-Hsien Chu; Shijun Wang; Chia-Ling Li; Shih-Heng Chen; Chih-Fen Hu; Yi-Lun Chung; Shiou-Lan Chen; Qingshan Wang; Ru-Band Lu; Hui-Ming Gao; Jau-Shyong Hong
Journal:  Brain Behav Immun       Date:  2016-04-27       Impact factor: 7.217

Review 9.  CSF-1 receptor signaling in myeloid cells.

Authors:  E Richard Stanley; Violeta Chitu
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

10.  M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification.

Authors:  Graham D Jack; Li Zhang; Alan D Friedman
Journal:  Blood       Date:  2009-07-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.